ZyVersa Therapeutics's total assets for Q3 2024 were $19.42M, a decrease of -0.23% from the previous quarter. ZVSA total liabilities were $12.40M for the fiscal quarter, a 14.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.